Simon Quick Advisors 13F: Adds $3.7M to Eli Lilly and (LLY) Stake
Key Points
- Simon Quick Advisors increased its holdings in Eli Lilly by 3,235 shares, a 55.6% increase, as reported in its latest Form 13F filing.
- Simon Quick Advisors held 9,049 $LLY shares at quarter end, up 55.64% from the prior quarter.
- The stock closed at $1,279.14 on October 26, 2026, and recently traded around $1,279.16, showing stability near its current levels.
- Eli Lilly has a market cap of approximately $1.14 trillion and is set to report earnings on October 29, 2026.
Get Eli Lilly and Company text alerts
We text you when insiders, Congress, analysts or big funds move on $LLY.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Eli Lilly and Company alert may contain errors. Disclosures
On October 26, 2026, Simon Quick Advisors boosted its stake in Eli Lilly and Company (LLY) by 3,235 shares, bringing its total to 9,049 shares valued at approximately $10.5 million. This information comes from the fund's latest Form 13F filing with the SEC.
LLY
Eli Lilly and Company
What Changed in Simon Quick Advisors' Position
Simon Quick Advisors increased its holdings in Eli Lilly by 3,235 shares, which is a 55.6% increase from its previous position of 5,814 shares. The reported value of this stake now stands at about $10.5 million, reflecting the fund's growing confidence in the company.
Where Eli Lilly Fits in Simon Quick Advisors' Portfolio
Eli Lilly now represents 0.78% of Simon Quick Advisors' total reported 13F value of approximately $1.34 billion, ranking 26th among its 455 positions.
Other Institutional Activity in Eli Lilly
Several other funds have been active in Eli Lilly recently. Gf Fund Management grew its holdings by 18,038 shares, totaling 40,491 shares worth about $46.9 million. Ag2R la Mondiale Gestion D'Actifs added 2,948 shares, bringing its total to 38,166 shares valued at approximately $44.2 million. Meanwhile, First Horizon trimmed its position by 727 shares, now holding 12,712 shares worth about $14.7 million.
Eli Lilly and Company Stock Up 0.4%
Eli Lilly's stock closed at $1,279.14 on October 26, 2026, and has recently traded around $1,279.16. The shares are currently above their 50-day moving average by 7.6% and 17.8% above their 200-day moving average, indicating strong performance over the medium to long term.
Recent Earnings
Eli Lilly reported trailing twelve-month revenue of approximately $79.7 billion, with an EPS of $29.79. The company is scheduled to report its next earnings on October 29, 2026.
Analysts Set New Price Targets
Analysts remain positive on Eli Lilly, with firms like JP Morgan and Morgan Stanley maintaining an Overweight rating. JP Morgan has a price target of $1,500, while Morgan Stanley's target is set at $1,430.
About Eli Lilly
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products globally, including in the U.S., Europe, and Asia. The company's strong revenue growth and robust product pipeline make it a significant player in the healthcare sector.
Bottom Line
Investors should keep an eye on Eli Lilly's upcoming earnings report on October 29, 2026, as well as any further institutional filings that may indicate shifts in investor sentiment. Simon Quick Advisors' recent boost in shares suggests a growing belief in the company's potential.
Related Filing Alerts
Source: Simon Quick Advisors's 13F filing on $LLY (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts